Latest filing published 06 Jul 2026 for LSL Pharma Group Inc.. Read the official filing
Guy Paul Allard appears in our data through filings on LSL Pharma Group Inc. shares, published by SEDI. Over a trading history stretching from 4 November 2024 to 3 July 2026, the count stands at 6 filings.
The open-market record is one-sided, with 4 purchases worth €4,783 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 option exercise. Since January 2026: 4 purchases and no sales on the market.
The median purchase comes to €479. As a share of market capitalisation, the median purchase stands at 0.0019%, based on 4 purchases. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.
On 6 July 2026 came the latest disclosure, an option exercise in LSL Pharma Group Inc. The latest purchase dates back some time: it was published 107 days ago, on 2 July 2026. The median gap between a trade and its publication by SEDI is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations